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Abstract
A large set of xenobiotic-metabolizing enzymes (XMEs), such as the cytochrome P450 monooxygenases (CYPs), esterases
and transferases, are highly expressed in mammalian olfactory mucosa (OM). These enzymes are known to catalyze the
biotransformation of exogenous compounds to facilitate elimination. However, the functions of these enzymes in the
olfactory epithelium are not clearly understood. In addition to protecting against inhaled toxic compounds, these enzymes
could also metabolize odorant molecules, and thus modify their stimulating properties or inactivate them. In the present
study, we investigated the in vitro biotransformation of odorant molecules in the rat OM and assessed the impact of this
metabolism on peripheral olfactory responses. Rat OM was found to efficiently metabolize quinoline, coumarin and isoamyl
acetate. Quinoline and coumarin are metabolized by CYPs whereas isoamyl acetate is hydrolyzed by carboxylesterases.
Electro-olfactogram (EOG) recordings revealed that the hydroxylated metabolites derived from these odorants elicited lower
olfactory response amplitudes than the parent molecules. We also observed that glucurono-conjugated derivatives induced
no olfactory signal. Furthermore, we demonstrated that the local application of a CYP inhibitor on rat olfactory epithelium
increased EOG responses elicited by quinoline and coumarin. Similarly, the application of a carboxylesterase inhibitor
increased the EOG response elicited by isoamyl acetate. This increase in EOG amplitude provoked by XME inhibitors is likely
due to enhanced olfactory sensory neuron activation in response to odorant accumulation. Taken together, these findings
strongly suggest that biotransformation of odorant molecules by enzymes localized to the olfactory mucosa may change
the odorant’s stimulating properties and may facilitate the clearance of odorants to avoid receptor saturation.
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Introduction
In mammals, the process of olfaction begins in the olfactory
epithelium with the binding of odorant molecules to membrane
receptors expressed by olfactory sensory neurons (OSNs). This
interaction triggers intracellular reaction cascades that transduce
the chemical signal into electrical activity, which is then conveyed
to the brain for further processing. There is growing evidence that
the activation of olfactory receptors (ORs) can be influenced by
biochemical events that occur in the vicinity of the OSNs. These
perireceptor events may regulate the transport, residence time and
clearance of odorants in the receptor environment [1,2].
A number of proteins in the mucus covering the olfactory
epithelium can catalyze these processes. Among them, odorant
binding proteins (OBPs) may play an important role in the
solubilization and transport of odorant molecules in the mucus [3].
Enzymes secreted in the mucus have been shown to biotransform
such odorants as aldehydes and esters [4,5]. Furthermore,
numerous xenobiotic-metabolizing enzymes (XMEs) are highly
expressed in mammalian olfactory mucosa (OM) [6,7]. XMEs
catalyze the biotransformation of a wide range of foreign
molecules, called xenobiotics, and of many endogenous com-
pounds. These enzymes often act sequentially. First, phase I
enzymes (e.g., cytochrome P450 monooxygenases (CYPs), carbox-
ylesterases, etc.) functionalize xenobiotics by forming polar
metabolites. Then, phase II enzymes such as UDP-glucuronosyl
transferases (UGTs) or glutathione-S-transferases conjugate meta-
bolites with a polar moiety (e.g., UDP-glucuronic acid, glutathi-
one, etc.) to increase compound hydrophilicity. The last step
(phase III) involves transporters that facilitate the excretion of
conjugated metabolites from the cell [8,9].
The functions of XMEs found in the olfactory epithelium,
however, are still not clearly understood. These enzymes most
likely play a primary role in protecting the olfactory epithelium
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against inhaled chemicals [10]. They may also protect the brain
because the olfactory nerve can carry viruses, bacteria and
chemicals into the brain [11–13]. Furthermore, XMEs may play
an active role in modulating olfactory input through metabolizing
odorant molecules [14,15]. This process could modify the
olfactory-stimulating properties of the odorants.
Although this is a standing hypothesis, no study has clearly
demonstrated that olfactory XMEs influence olfactory signals in
mammals. In contrast, in insects, a growing set of data suggests
that several enzymes such as esterases or aldehyde oxidases found
in the sensilla lymph of antennae have the ability to metabolize
odorant molecules and pheromones [4,16,17]. Interestingly, recent
functional studies have shown that intracellular CYPs and
carboxylesterases from scarab beetle and moth antennae can also
catalyze the biotransformation of volatile compounds [18,19].
Inhibition of CYPs by a specific inhibitor induces anosmia in the
pheromone-detecting OSNs, demonstrating that CYPs are in-
volved in pheromone metabolism [18]. Given the numerous
similarities between insect and mammalian olfactory systems [20],
these findings strongly support the possibility that olfactory XMEs
may also modulate olfactory signals in mammals.
Thus, we designed the present study to assess the impact of
phase I XMEs on olfactory epithelial responses to odorant
stimulations in the rat. We studied the in vitro biotransformation
of three odorant molecules (quinoline, coumarin and isoamyl
acetate) to evaluate the metabolic capacity of the OM and to
identify the products formed. Subsequently, we performed
electroolfactogram (EOG) recordings to compare the intensity of
the olfactory responses elicited by these odorant molecules and
those elicited by their metabolites. Lastly, we examined the effects
of in situ treatment with 1-aminobenzotriazole (ABT) and bis-p-
nitro-phenylphosphate (BNPP), specific inhibitors of CYPs and
carboxylesterases, respectively, on peripheral olfactory responses
to these odorants. Our results demonstrated that XMEs localized
to mammalian OM can efficiently biotransform odorants and
modulate peripheral olfactory responses.
Results
In vitro Metabolism of Odorant Molecules
Metabolism of quinolone. When quinoline was incubated
with olfactory microsomes and NADPH, several metabolites were
formed (Fig. 1A). Mass spectrometry analysis indicated that these
compounds are oxygenated metabolites (mono-hydroxylated and
diol derivatives) (Fig. S1). Quinoline-1-oxide and quinoline-5,6-
epoxide appeared to be the major metabolites. Quinoline-1-oxide
was identified by comparing its mass spectra with that of the
standard compound (Fig. S2). Because the standard of quinoline-
5,6-epoxide was not commercially available, this compound was
identified by comparing its UV spectra to previously published
spectra [21] and by taking into account its molecular mass given
by mass spectrometry analysis. Mass spectrometry analysis also
indicated that the peak X2 would correspond to diols (Fig. S3).
With the exception of X4, no metabolite was formed when the
Figure 1. Representative HPLC profiles of quinoline metabolites formed in vitro by rat hepatic and olfactory microsomes. Four
experimental conditions are shown: (A) reaction mixture containing olfactory microsomes and NADPH; (B) reaction mixture containing olfactory
microsomes but no NADPH; (C) reaction mixture containing hepatic microsomes and NADPH; (D) reaction mixture containing hepatic microsomes
but no NADPH.
doi:10.1371/journal.pone.0059547.g001
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incubation medium lacked NADPH (Fig. 1B). Hepatic micro-
somes produced a similar profile of metabolites, but the resulting
biotransformation intensity was lower than that resulting from
olfactory microsome incubation (Fig. 1C). No metabolites were
detected when hepatic microsomes were incubated without
NADPH (Fig. 1D). Due to the availability of the standard, the
rate of quinoline-1-oxide formation could be quantified. The rate
of quinoline-1-oxide formation in olfactory microsomes was 3-fold
higher than that in hepatic microsomes (0.37 nmol/min/mg
protein and 0.11 nmol/min/mg protein, respectively). The HPLC
profiles of olfactory and hepatic microsome incubations without
NADPH indicated that X4 formation induced by olfactory
microsomes is CYP-independent. The addition of ABT, a general
CYP inhibitor [22], resulted in dose-dependent inhibition of the
quinoline metabolism catalyzed by olfactory microsomes (Fig. 2A).
The IC50 values of ABT for inhibition of quinoline-1-oxide and
quinoline-5,6-epoxide formation were 134 and 147 mM, respec-
tively. ABT at the concentration of 400 mM decreased the
metabolism of quinoline by approximately 80%. The olfactory
metabolism of quinoline was not affected by BNPP, a specific
inhibitor of carboxylesterases [23] (data not shown).
Metabolism of coumarin. Results from HPLC analysis of
metabolites formed by incubating coumarin with olfactory or
hepatic microsomes are shown in Fig. 3. Mass spectrometry
analysis indicated that these compounds are oxygenated deriva-
tives of coumarin (Fig. S4). After comparison of mass spectra with
those of authentic standards (Fig. S5), we identified three main
metabolites (7-hydroxycoumarin, 6-hydroxycoumarin and 3-
hydroxycoumarin) in reactions involving olfactory microsomes
(Fig. 3A). Low quantities of unidentifiable metabolites were also
detected (peak X1). No metabolite was formed when NADPH was
omitted (Fig. 3B). In contrast, only a small amount of one
unidentifiable metabolite (peak X2) was formed when coumarin
was incubated with hepatic microsomes (Fig. 3C). This metabolite
was not found when NAPDH was omitted (Fig. 3D). The rate of
coumarin biotransformation measured in OM incubation was 65-
fold higher than that measured in liver incubation (13.3 nmol/
min/mg protein and 0.2 nmol/min/mg protein, respectively).
Furthermore, the addition of ABT to the olfactory microsome
incubation inhibited formation of coumarin metabolites in a dose-
dependent manner (Fig. 2B). ABT inhibited 3-hydroxy-, 6-
hydroxy- and 7-hydroxycoumarin formation with IC50 values of
41, 52 and 19 mM, respectively. Ninety percent of metabolite
formation was inhibited by 400 mM of ABT. However, coumarin
metabolism was not affected by the addition of BNPP (data not
shown).
Metabolism of isoamyl acetate. Carboxylesterases hydro-
lyze volatile esters to their corresponding acids [24]. Thus, we
assessed the hydrolysis of isoamyl acetate by measuring acetic acid
liberation in the reaction medium following incubation with
olfactory or hepatic S9 fractions. Esterase activity was equivalent
in both tissues (approximately 390 mmol acetic acid/mg protein/
min) (Fig. 4A). Isoamyl acetate hydrolysis in the olfactory S9
fraction was inhibited in a dose-dependent manner by BNPP,
a specific carboxylesterase inhibitor, with an IC50 value of 0.8 mM
(Fig. 4B). In contrast, ABT had no effect on isoamyl acetate
hydrolysis, which confirmed that this reaction was not dependent
on the CYP enzymes (data not shown). These data indicate that
carboxylesterases metabolize isoamyl acetate in the OM and liver
and form acetic acid and isoamyl alcohol as metabolites.
EOG Responses to Odorant Molecules and Odorant
Molecule Derivatives
To assess the impact of biotransformation on the olfactory
properties of the odorant molecules, we measured EOG responses
to commercially available odorants and odorant metabolites. We
also included other putative odorant derivatives (e.g., hydroxylat-
ed, methylated and glucurono-conjugated compounds) in these
experiments. EOGs were recorded at concentrations of 1 mM,
10 mM and 100 mM.
The EOG responses induced by quinoline were compared to
those induced by two hydroxylated metabolites, quinoline-1-oxide
(Q-1-O) and 8-hydroxyquinoline (8-OH-Q), and the glucurono-
conjugated metabolite 8-hydroxyquinoline-b-D-glucuronide (8-
OH-Q-G). The EOG amplitudes were recorded at different
locations on the olfactory epithelium (Fig. 5A) and normalized to
Figure 2. Inhibition of quinoline and coumarin microsomal
metabolism by the CYP inhibitor ABT. (A) Effect of ABT on
quinoline metabolism; (B) effect of ABT on coumarin metabolism.
Values represent mean of 3 replicates 6 S.E.M.
doi:10.1371/journal.pone.0059547.g002
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IBMX responses. A representative EOG recording is shown in
Fig. 5B. Regardless of the recording site, similar patterns of
responses were observed when 100 mM of quinoline and quinoline
derivatives were applied (Fig. 5C). The EOG responses to the two
oxygenated products, 8-OH-Q and Q-1-O, was half of that
elicited by quinoline. Glucuronide 8-OH-Q-G elicited a response
equivalent to that induced by 0.01% dimethylsulfoxide (DMSO),
which was used as vehicle. This result indicated that 8-OH-Q-G
induced no olfactory response. At lower concentrations (1 and
10 mM), the compounds produced comparable response profiles
but with lower amplitudes than those recorded at 100 mM
(Fig. 5D).
Similarly, the EOG responses to coumarin were compared to
those induced by two hydroxylated metabolites, 4- and 7-
hydroxycoumarin (4-OH-C and 7-OH-C), and the methylated
derivative 4-methyl-coumarin (4-MC). The EOG responses to 4-
MC were also compared to the responses elicited by the
hydroxylated derivative 4-methylumbelliferone (4-MU) and to
a glucurono-conjugated derivative of 4-MU, 4-methylumbellifer-
one-b-D-glucuronide (4-MU-G). The hydroxylated derivatives of
coumarin (4-OH-C and 7-OH-C) and that of 4-MC (4-MU)
elicited EOG amplitudes significantly lower than those induced by
their parent compounds regardless of the applied concentration
(Fig. 6). Furthermore, responses to 4-MC were lower in amplitude
than the responses to coumarin. Low EOG amplitudes were also
observed when the glucurono-conjugated derivative 4-MU-G was
applied on the turbinates. The amplitudes of these responses were
equivalent to those elicited by 0.01% DMSO. We therefore
concluded that 4-MU-G did not elicit any measurable EOG
response.
Because the metabolism of isoamyl acetate creates isoamyl
alcohol and acetic acid, we also measured EOG responses to each
of these compounds. The results showed that the amplitudes of
EOG responses to isoamyl alcohol were approximately 60% lower
than those elicited by isoamyl acetate at any concentration (Fig. 7).
Similar pattern of responses was recorded regardless the recording
site Concerning acetic acid, we observed that repeated application
of this compound on the OM caused tissue damage, making EOG
recordings unreliable.
Effects of XME Inhibitors on EOG Responses
To investigate the functional role of the olfactory XMEs, we
recorded odorant-induced EOG responses before and after
applying two phase I enzyme inhibitors, ABT and BNPP. First,
we confirmed that superfusion of OM with ABT or BNPP was
sufficient to inhibit CYP and carboxylesterase activities, re-
spectively. For this purpose, the in vitro metabolism of quinoline,
coumarin and isoamyl acetate was measured. All steps were
performed as described previously except that the microsomal or
S9 fractions were prepared from OM that had been superfused
with inhibitors for 20 min. Superfusion of the OM with 400 mM of
ABT or BNPP decreased the metabolism of quinoline/coumarin
or isoamyl acetate, respectively, by approximately 30 to 80% (Fig.
S6). In addition, we verified that the magnitude of 3-isobutyl-1-
methylxanthine (IBMX)-induced EOG responses did not vary
before and after inhibitor application to demonstrate that inhibitor
treatment does not interfere with signal transduction in OSNs
(data not shown).
The protocol presented in Fig. 8 was implemented to study the
impact of enzyme inhibitors on EOG response. Before perfusion
with ABT, we observed that successive stimulations by odorants at
2-min intervals produced identical EOG response amplitudes
(Fig. 9). Treatment of the olfactory epithelium with ABT
Figure 3. Representative HPLC profiles of coumarin metabolites formed in vitro by rat hepatic and olfactory microsomes. Four
experimental conditions are shown: (A) reaction mixtures containing olfactory microsomes and NADPH; (B) reaction mixtures containing olfactory
microsomes but no NADPH; (C) reaction mixtures containing hepatic microsomes and NADPH; (D) reaction mixtures containing hepatic microsomes
but no NADPH.
doi:10.1371/journal.pone.0059547.g003
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significantly increased the maximum EOG amplitudes elicited by
coumarin and quinoline by 43% and 32%, respectively (Fig. 9).
Interestingly, subsequent stimulations produced significantly lower
EOG amplitudes. There was an 8-min refractory period before the
same amplitude as that recorded just after ABT treatment could
be recovered. Conversely, ABT treatment did not affect EOG
responses to isoamyl acetate, a compound that is not metabolized
by CYPs (Fig. 9). The EOG amplitudes elicited by isoamyl acetate
before and after application of this inhibitor were identical. The
onset and decay slopes of EOG recordings were stable over time
and unaffected by ABT treatment (Fig. S7). Similarly, BNPP
treatment significantly increased the maximal EOG response
amplitude to isoamyl acetate by 30% (Fig. 10). As previously
observed with ABT treatment, the EOG responses decreased
when the OM was stimulated again. Further, we observed that the
EOG response recovered to the initial levels following an 8-min
refractory period. BNPP treatment did not modify the onset or
decay slopes of EOG responses (Fig. S8). The EOG responses
elicited by quinoline, which is not a carboxylesterase substrate,
were not modified by BNPP treatment (Fig. 10).
Discussion
The goal of this study was to determine whether odorant
metabolism by olfactory tissue enzymes modulates the first step of
olfactory perception. Because data on odorant biotransformation
by the OM are scarce, we studied the phase I metabolism of
several odorant molecules. Then, we evaluated the consequences
of biotransformation on the stimulating properties of these
odorants. We accomplished this step by comparing EOG
responses to odorants and their derivatives and by measuring
EOG responses following phase I enzyme inhibition. Collectively,
these studies demonstrate that the OM can enzymatically modify
odorant molecules and thus change their stimulating properties.
OM has a High Odorant-metabolizing Capacity
In vitro metabolism studies have shown that the rat OM has the
capacity to efficiently biotransform odorants such as quinoline,
coumarin and isoamyl acetate. The extent of quinoline metabo-
lism was higher in OM microsomes than in hepatic microsomes.
Several hydroxylated metabolites, including quinoline-5,6-epoxide
and quinoline-1-oxide, were formed following the phase I
metabolism of quinoline. Similarly, the rate of coumarin
metabolism in OM was much higher than the rate in the liver.
This finding is consistent with previous studies [25]. The major
metabolites formed by olfactory microsomes were 7-OH-coumarin
and 6-OH-coumarin. The formation of o-hydrophenylacetalde-
hyde, a derivative of coumarin-3,4-epoxide, could not be
measured in our experimental conditions because the detection
of this ring-opened compound requires specific methods [26]. The
strong decrease in metabolite formation observed when micro-
somes were pre-incubated with ABT suggests that CYPs are
responsible for the metabolism of coumarin and quinoline.
Previous reports have indicated that CYP2A3 and CYP2G1,
which are highly expressed in rat OM, are involved in coumarin
hydroxylation [25,27]. The CYPs involved in the metabolism of
quinoline in the OM are not known. However, quinoline is known
to inhibit coumarin-7-hydroxylation, a reaction mainly catalyzed
by CYP2A3 [28]. Thus, CYP2A3 also likely contributes to the
biotransformation of quinoline in olfactory microsomes. In this
study, furthermore, we showed that isoamyl acetate is readily
metabolized by olfactory carboxylesterases. This result is in
agreement with previous reports of high carboxylesterase activity
in the OM [24,29]. Taken together, these findings confirm that the
rat OM displays remarkable odorant-metabolizing capacity. This
property is closely related to high XME expression in the OM as
previously reported by our group and others [7,30–34].
Odorants and their Derivatives Elicit Different Olfactory
Responses
EOG responses to the hydroxylated derivatives of quinoline,
coumarin and isoamyl acetate were significantly lower in
amplitude than those elicited by the parent compounds. These
results demonstrate that biotransformation modifies the olfactory-
stimulating properties of odorants. It is generally thought that
Figure 4. Hydrolysis of isoamyl acetate by olfactory and
hepatic tissues and impact of the carboxylesterase inhibitor
BNPP. (A) Hydrolase activity of rat olfactory and hepatic S9 fractions
(mean 6 S.E.M., n = 3 replicates); (B) inhibitory effect of BNPP on
olfactory hydrolase activity (mean 6 S.E.M., n = 3 replicates).
doi:10.1371/journal.pone.0059547.g004
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EOG amplitudes represent the sum of generator potentials created
by individual OSNs in the recording field [35]. Changes in EOG
amplitude can therefore result from variation in the number of
activated OSNs (i.e., the number of activated ORs) or from
variation in the intensities of individual neuron responses.
Recently, using a heterologous expression system to study the
activation profiles of approximately 460 mammalian ORs, Saito
et al. showed that coumarin activated 20 ORs whereas 4-
hydroxycoumarin only activated one OR, mOR41-1 [36].
Though this receptor was activated by both compounds, coumarin
was more potent than its hydroxylated derivative. These data are
in agreement with our observations, indicating that odorant
hydroxylation can reduce both the numbers of activated OSNs
and their individual response intensities. It is nevertheless difficult
to generalize this finding. Indeed, a number of odorants possessing
a hydroxyl group have been shown to efficiently activate ORs
[36,37]. In some cases, the presence of a hydroxyl group seems to
even be essential for agonist activity. For example, the tertiary
alcohol moiety of lyral is primarily responsible for activating the
murine receptor MOR23 and generating an olfactory response
[38]. A functional study of the mouse receptor mOR-EG also
demonstrated the importance of a hydroxyl group attached to the
benzene ring of odorants in activating this receptor [39]. This
hydroxyl group forms a hydrogen bound with a specific amino
acid in the receptor and is essential for ligand binding.
In addition to the impact of hydroxylation, we also examined
the consequence of glucuronidation on olfactory properties of
odorants. Indeed, significant glucuronidation activities have been
reported in the rat OM [7,15]. In particular, we observed that
glucuronidation of the coumarin derivative 4-MU is higher in the
OM than in the liver, indicating that the OM has the capacity to
glucurono-conjugate efficiently coumarin metabolites [7]. In the
present study, we demonstrated that the glucurono-conjugated
metabolites of quinoline and coumarin were unable to elicit EOG
responses. This finding is in accordance with a previous study
showing that olfactory cAMP production in vitro is stimulated by
Figure 5. EOG response amplitudes elicited by quinoline and the quinoline derivatives. (A) Sagittal image of the rat olfactory system
following sectioning of the head and removal of the nasal septum (roman numerals designate individual turbinates and arabic numerals indicate the
sites at which odor responses were recorded). (B) Representative EOG recordings generated by quinoline and its derivatives (100 mM). (C) EOG
response amplitudes recorded at different turbinate sites after stimulating the OM with quinoline and its derivatives (100 mM). The sign# indicates
that EOG responses have not been recorded on these sites. (D) EOG response amplitudes induced by 1, 10 and 100 mM of quinoline and its
derivatives (average of data recorded at different sites). Data are expressed as the mean 6 S.E.M. (n = 4 rats). Asterisks (*) indicate significant
differences between stimulation levels elicited by quinoline and the quinoline derivatives (Mann-Whitney test, p#0.05).
doi:10.1371/journal.pone.0059547.g005
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parent odorants but not their glucuronidated derivatives [14].
Mitral cell response is also low in rats exposed to odorants that are
efficiently glucurono-conjugated by the OM [15]. The rodent OM
predominantly expresses the UGT2A1 isoform, but the UGT2A2
and UGT1A6 isoforms have also been detected [7,15,40].
UGT2A1 is expressed in sustentacular cells, Bowman glands
and, interestingly, in olfactory sensory cilia [14,40,41]. This
expression pattern supports the hypothesis that olfactory UGTs
are involved in the extinction of olfactory signals. Indeed, the
conjugation of odorants with large hydrophilic entities such as
glucuronic acid increases steric hindrance and therefore may
hinder interactions with OR.
Mucosal XMEs Modulate Peripheral Olfactory Responses
As we observed that biotransformation of odorants occurs
significantly in OM, we postulated that this process could affect the
olfactory responses. If this is the case, this would mean that the
amplitudes of EOG responses to odorants, but also perhaps to
their metabolites, that have been recorded take into account the
impact of biotransformation processes. As EOG amplitudes
elicited by metabolites are lower than those induced by the parent
compounds, this would result finally in a decrease in EOG
amplitudes. Similarly, it could also be assumed that metabolic
reactions can modulate responses elicited by hydroxylated
metabolites since numerous phase 2 enzymes (such as UGTs)
are expressed in the olfactory mucosa. Therefore, to assess the
influence of peripheral XMEs on olfactory responses, we
compared EOG responses before and after treatment of the OM
with ABT and BNPP, two inhibitors that irreversibly inactivate
CYPs and carboxylesterases, respectively [22,23]. ABT treatment
of the olfactory epithelium increased EOG responses elicited by
quinoline and coumarin (which are metabolized by CYPs) but did
not modify the EOG response to isoamyl acetate. Conversely,
BNPP treatment modified EOG responses to isoamyl acetate
(which is metabolized by carboxylesterases) but not those elicited
by quinoline and coumarin. These observations indicate that the
inhibitors do not affect OSN receptor-transduction mechanisms
but do target enzymes (CYPs and carboxyl esterases) that
modulate olfactory responses. The increase in EOG responses
observed following inhibitor application may result from an
increased number of recruited receptors or from modification of
odorant affinity for olfactory receptors. Furthermore, the kinetics
of the EOG responses were not affected by ABT or BNPP,
indicating that these treatments did not perturb the OSN
environment. However, a slight decrease in EOG amplitude was
observed when OM was stimulated repeatedly with odorants after
inhibitor treatment. This effect could be a consequence of
neuronal adaptation that occurs when OSNs are continuously
exposed to odorants to prevent saturation of the cellular trans-
duction machinery [42]. We speculate that XME inhibition
drastically slows the metabolism of odorants, thereby prolonging
Figure 6. Normalized EOG maximum amplitudes elicited by 1, 10 and 100 mM of coumarin and the coumarin derivatives. Data are
expressed as the means of data recorded at different sites6 S.E.M. (n = 4 rats). Asterisks (*) indicate significant differences between stimulations levels
elicited by coumarin and coumarin derivatives (Mann-Whitney test, p#0.05).
doi:10.1371/journal.pone.0059547.g006
Figure 7. Normalized EOG maximum amplitudes elicited by 1,
10 and 100 mM of isoamyl acetate and isoamylic alcohol. Data
are expressed as the mean of data recorded at different sites 6 S.E.M.
(n = 4 rats). Asterisks (*) indicate significant differences between the
stimulation elicited by isoamyl acetate and isoamylic alcohol (Mann-
Whitney test, p#0.05).
doi:10.1371/journal.pone.0059547.g007
Odorant Metabolism Influences Olfactory Responses
PLOS ONE | www.plosone.org 7 March 2013 | Volume 8 | Issue 3 | e59547
the presence these molecules in the perireceptor space and
inducing OSN adaptation. XMEs may therefore participate in
maintaining olfactory system sensitivity.
Because enzymes localized to the nasal mucus can also convert
odorants such as vanillin [5], it cannot be ruled out that the mucus
enzymes had an impact on our study. However, previous
observations showed that washing the olfactory epithelium with
Ringer buffer strongly increased the response amplitude of
olfactory bulb glomerulus to vanillin, indicating that a large
portion of the mucus was removed by washing [43]. Therefore the
enzymes targeted by the inhibitors are likely localized in the OM.
XMEs have been detected in different cell types, including
sustentacular cells and the cilia of OSNs [10,44]. XMEs are
classically found inside cells, mostly in the endoplasmic reticulum
and in the cytosol. This localization seems to be incompatible with
a fast metabolism of odorant molecules. A possibility might be that
odorants could be biotransformed by enzymes present in the
plasma membrane of cells. Indeed, a number of studies reported
the presence of CYPs at the extracellular face of the plasma
membrane of different mammal cell types (for a review, see [45]).
These studies also demonstrated that these membrane enzymes
were catalytically active, suggesting they might play a role in the
metabolism of xenobiotics. The presence of active CYPs, and
perhaps other XMEs, at the cell surface of olfactory cells, close to
the receptors, could have an impact both on the intensity and the
quality of olfactory signals. This assumption is supported by
a recent study that reported detection of odorant metabolites in
the exhaled air following odorant inhalation in human subjects
[46]. In the same study, the inhalation of a CYP inhibitor with
a ketone odorant modified the odor quality perceived by the
participants, indicating that metabolites formed by CYPs contrib-
uted to the ketone odor [46]. These findings support the idea of
a fast metabolic process and indicate that metabolites formed by
olfactory XMEs, particularly those issued from CYP-catalyzed
reactions, can participate in olfactory coding and thus noticeably
affect odor quality.
In conclusion, the present study demonstrates that the olfactory
mucosa has the capacity to efficiently metabolize odorant
molecules and that odorant metabolism can modulate the intensity
of olfactory responses. Our findings, together with the observations
made by Nagashima et al. [5], support the idea that enzymes in
the environment surrounding olfactory receptors, i.e., in the
olfactory mucosa and mucus, shape olfactory perception by
modulating both the intensity and quality of odorant signals.
Evaluating the contribution of different metabolic events in this
process would enhance our understanding of peripheral chemo-
sensory mechanisms.
Materials and Methods
Chemicals
The odorant molecules, their derivatives and the enzyme
inhibitors used in this study were purchased from Sigma-Aldrich
(Saint-Quentin Fallavier, France), Interchim (Montluc¸on, France)
or Merck (Fontenay sous Bois, France). The chemical structures
and molecule characteristics of these compounds are presented in
Fig. 11 and Table S1, respectively. All compounds were of the
highest available quality.
Ethics Statement
The experiments were carried out in accordance with the
French Ministry of Agriculture guidelines for the care and use of
laboratory animals. The experimental protocol was approved by
the local animal ethics committee of the University of Burgundy,
Dijon, France (approval number EXT0109).
Animals
Seven-week-old male Wistar rats were purchased from Janvier
(Le Genest Saint Isle, France). Animals were housed in temper-
ature- (20–22uC) and relative humidity-controlled (30–70%)
conditions with a 12-h light/dark cycle. Animals had free access
to water and A04-10 food pellets (Safe, Augy, France).
Metabolism of Odorant Molecules
Preparation of microsomal and S9 fractions. Animals
were sacrificed by decapitation. Livers and OM were immediately
removed and snap-frozen in liquid nitrogen. OM included both
endoturbinates I to IV and ectoturbinates 1 to 4, according to the
nomenclature of Ressler et al. [47]. Samples were stored at280uC
until they were differentially centrifuged to obtain microsomes and
S9 fractions. Pools of five OM were homogenized in 2 mL of
50 mM Tris-HCl buffer (pH 7.5) containing 0.25 M sucrose and
1 mM EDTA using an Ultra-Turrax homogenizer. The homog-
enate was centrifuged twice at 1500 g for 10 min to discard debris.
Figure 8. Schematic representation of the experimental protocol used to assess the effect of enzyme inhibitors (ABT and BNPP) on
odorant-induced EOG responses.
doi:10.1371/journal.pone.0059547.g008
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The supernatant fraction was then centrifuged at 8500 g for
10 min then at 14 500 g for 20 min. The supernatant fraction
obtained following this step was designated the S9 fraction. To
obtain microsomes, the S9 fraction was centrifuged at 105 000 g
for 60 min. The resulting pellet was resuspended in homogeniza-
tion buffer. Hepatic subcellular fractions were prepared as
described previously [48]. Microsomes and S9 fractions were
stored in small aliquots at 280uC until use. The protein levels of
these fractions were quantified by the method of Bradford [49]
using bovine serum albumin as a standard.
Metabolism assays. Incubations of odorants (coumarin,
quinoline and isoamyl acetate) with subcellular fractions were
carried out as described in Table S2. Coumarin and quinoline
were incubated with microsomes in order to investigate the ability
of enzymes localized in the endoplasmic reticulum (mainly CYPs)
to metabolize these odorants. As the mammalian carboxylesterases
are localized in the endoplasmic reticulum and in the cytosol of
cells [50], isoamyl acetate biotransformation was examined by
incubating this compound with S9 fraction. Reactions were
performed in triplicate at 37uC and were initiated by adding
odorant to the mixtures after a 5-min pre-incubation period.
Reactions involving coumarin and quinoline were carried out for
30 min and 90 min, respectively, and were terminated by adding
100 ml of ice-cold acetonitrile. Subsequently, the products were
Figure 9. Time course of normalized EOG maximum amplitudes elicited by coumarin, quinoline and isoamyl acetate before and
after ABT treatment (the protocol is presented in Fig. 8). EOG responses were recorded from the endoturbinate IIb. Data are expressed as the
mean 6 SEM (n= 5 rats). Data notated by distinct letters are significantly different (Bonferroni test, p#0.05).
doi:10.1371/journal.pone.0059547.g009
Odorant Metabolism Influences Olfactory Responses
PLOS ONE | www.plosone.org 9 March 2013 | Volume 8 | Issue 3 | e59547
centrifuged at 12 000 g for 10 min. An aliquot of the supernatant
(100 ml) was analyzed by reverse phase high performance liquid
chromatography (HPLC) using a Waters HPLC system (Milford,
MA, USA) equipped with a pump (model 600), an autosampler
thermostat set at 10uC (model a717 plus), a photodiode array UV
detector (model 996) and an Uptisphere C18-ODB column (5-mm
particle size, 15064.6 mm; Interchim, Montluc¸on, France). The
effluent from the column was routed to an UV detector, which can
scan wavelengths from 210 to 400 nm. The solvent gradient
program used to separate quinoline and its metabolites was set at
5% methanol in water for 5 min followed by a linear gradient of
methanol increasing to 40% in 15 min (at 1 mL/min). The
separation of coumarin and its metabolites was achieved using
a solvent gradient program (at 0.6 mL/min) set at: 25%
acetonitrile/75% formic acid (0.01% in water) for 10 min, a linear
gradient to 80% acetonitrile for 20 min, hold at 80% acetonitrile
for 10 min, and then return to the initial conditions. Additionnal
liquid chromatography - mass spectrometry analyses were carried
out to identify quinoline and coumarin metabolites. Details about
instrumentation and results are given as supplemental information
(Text S1).
Reactions involving isoamyl acetate were carried out for 10 min
and were terminated by heating at 80uC for 15 min. After
centrifugation at 12000 g for 10 min, isoamyl acetate metabolism
was assessed by quantifying the acetate in a sample volume of
100 mL using an acetic acid assay kit (Megazyme, Bray, Ireland).
Electrophysiological Studies
Stimuli solution preparation. Odorant stock solutions
(1 M) were prepared in DMSO. Working solutions were prepared
extemporaneously by diluting stock solutions with the Ringer
solution. The final concentration of DMSO in odorant solutions
did not exceed 0.01%. The IBMX stock solution (10 mM) was also
prepared in DMSO. This stock solution was diluted 100-fold with
the Ringer solution to produce a working solution (100 mM)
containing 0.1% DMSO.
Electroolfactogram recordings. To assess sensory re-
sponses induced by odorant stimulation of the olfactory mucosa,
we recorded EOGs. This method measures the summated,
odorant-induced generator potentials of the OSNs on the olfactory
epithelium surface [35]. We used a submerged EOG technique
because it allowed us to quantify responses elicited by non-volatile
and low-volatility compounds and to deliver pharmacological
agents [51]. Rats were sacrificed by CO2 exposure and de-
capitated. The head was hemisected and the nasal septum was
carefully removed to expose the endoturbinate system of the main
olfactory system. The tissue was then superfused continuously
(5 mL/min) at room temperature (22–25uC) with modified Ringer
buffer containing 140 mM NaCl, 5 mM KCl, 2 mM CaCl2,
2 mM MgCl2, 10 mM HEPES [4-(2-hydroxyethyl)-1-piperazi-
neethanesulfonic acid], adjusted to pH 7.2 and to 320 mOsm.L21
with glucose. Odorant stimuli were applied to the turbinates using
a custom-built odorant delivery system consisting of a Rheodyne
six-port injection valve equipped with a 200-mL loop. This valve
injects odorant into the continuous stream of the Ringer solution.
The distal part of the delivery system was fixed to a micromanip-
ulator and adjusted to produce uniform flow in the vicinity of the
recording electrode. The recording electrode was an Ag/AgCl
wire positioned in a disposable pipette tip filled with a conductive
gel (WPI, Sarasota, USA). The reference electrode was an 8-mm
diameter Ag/AgCl disk covered with conductive gel that was
Figure 10. Time course of normalized EOG maximum amplitudes elicited by isoamyl acetate and quinoline and before and after
BNPP treatment (the protocol is presented in Fig. 8). EOG responses were recorded from the endoturbinate IIb. Data are expressed as the
mean 6 SEM (n= 5 rats). Data notated by distinct letters are significantly different (Bonferroni test, p#0.05).
doi:10.1371/journal.pone.0059547.g010
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placed under the rat hemi-head. Electrical signals were amplified
using an AC/DC differential amplifier (A-M Systems, model 3000,
Phymep, Paris, France), run through a low-pass filter of 300 Hz,
digitized at 100 Hz using a Digidata 1440A interface board (Axon
Instruments, DIPSI Industrie, Chaˆtillon, France) and acquired
using Axoscope 10.2 software (Axon Instruments). The data were
analyzed using Clampfit software (Axon Instruments). The peak
amplitudes of EOG responses were measured at the maximum
negative voltage deflection from baseline. The data were
normalized by dividing the peak amplitude by the maximum
amplitude elicited by 100 mM of IBMX, a phosphodiesterase
inhibitor that activates the transduction pathway bypassing the
receptor step.
The protocol used to assess the effect of XME inhibitors (ABT
or BNPP) on EOG responses is presented in Fig. 8. First, two series
of odorant stimulations at 2-min intervals were performed with an
8-min recovery period between each series. Under control
conditions, a 2-min interval is sufficient to recover normal
response amplitude. Then, the inhibitor was diluted in the Ringer
buffer (final concentration 400 mM) and applied to the olfactory
turbinates at a rate of 2.5 mL/min for 20 min using the Rheodyne
injection valve. The preparation was rinsed for 5 min with the
Ringer buffer and the epithelium was stimulated by applying
odorant using the same procedures as described above. EOG
responses were recorded on endoturbinate IIb. IBMX was applied
at the end of each measurement series for data normalization as
described above. In addition to the peak maximum amplitude, the
onset slope (10% to 90%) and the fast decay slope (90% to 40%)
were measured and normalized to the corresponding EOG peak
amplitude.
Figure 11. Chemical structures and abbreviations of molecules used in the study.
doi:10.1371/journal.pone.0059547.g011
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Statistical Analysis
The non-parametric Mann-Whitney test was applied to assess
differences between the EOG response amplitudes induced by the
odorants and those induced by their derivatives. A two-way
repeated-measures ANOVA was used to analyze the data from the
EOG experiments involving enzyme inhibitors. When the
ANOVA revealed a statistically significant effect, the Bonferroni
post-hoc test was applied to compare EOG responses recorded
throughout the protocol. The results were considered to be
significant if p,0.05. All statistical analyses were carried out using
Statistica software (version 8; StatSoft, Maisons-Alfort, France).
Supporting Information
Figure S1 LC-ESI-MS/MS chromatograms (mode scan prod-
ucts of molecular ion [M+H]+) and UV-chromatogram (at
290 nm) of a mixture of authentic standards (quinoline and
quinoline-1-oxide) (A) and of metabolites formed after incubation
of quinoline with rat olfactory microsomes (B).
(TIF)
Figure S2 Product ion spectra of the molecular ions [M+H]+ at
m/z 146 of authentic standard of quinoline-1-oxide (A) and
compounds formed after incubation of quinoline with rat olfactory
microsomes (B).
(TIF)
Figure S3 Product ion spectra of the molecular ions [M+H]+ of
quinoline-derivated compounds at m/z 162.
(TIF)
Figure S4 LC-ESI-MS/MS chromatogram (mode scan prod-
ucts of molecular ion [M-H]- at m/z 161) and UV-chromatogram
(at 274 nm) of a mixture of authentic standards (coumarin, 7-
hydroxycoumarin, 6-hydroxycoumarin and 3-hydroxycoumarin)
(A) and of metabolites formed after incubation of coumarin with
rat olfactory microsomes (B).
(TIF)
Figure S5 Product ion spectra of the molecular ions [M-H]- at
m/z 161 of authentic standards of coumarin metabolites (A) and
compounds formed after incubation of coumarin with rat olfactory
microsomes (B).
(TIF)
Figure S6 Effect of superfusion of the olfactory mucosa with
400 mM ABT on quinoline (A) and coumarin (B) metabolite
formation and effect of superfusion with 400 mM BNPP on
carboxylesterase activity (C). Values represent mean of 3 replicates
6 S.E.M.
(TIF)
Figure S7 EOG onset (A) and decay (B) slopes elicited by
coumarin, quinoline and isoamyl acetate before and following
ABT treatment. Onset slopes (10% to 90%) and fast decay slopes
(90% to 40%) were normalized to the corresponding EOG peak
amplitude. Data are expressed as the mean 6 SEM (n = 5 rats).
No comparison was significantly different (Bonferroni test,
p#0.05).
(TIF)
Figure S8 EOG onset (A) and decay (B) slopes elicited by
isoamyl acetate and quinoline and before and after BNPP
treatment. Onset slopes (10% to 90%) and fast decay slopes
(90% to 40%) were normalized to the corresponding EOG peak
amplitude. Data are expressed as the mean 6 SEM (n = 5 rats).
No comparison was significantly different (Bonferroni test,
p#0.05).
(TIF)
Table S1 Characteristics of molecules used in the study.
(PDF)
Table S2 Incubation conditions used to study the in vitro
metabolism of odorants.
(PDF)
Text S1 Liquid chromatography - mass spectrometry analyses
(PDF)
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